Word: patentable
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...team of scientists set up a field trial of two transgenic lines?UH SunUP and UH Rainbow?and by 1996, the verdict had been rendered. The nontransgenic plants in the field trial were a stunted mess, and the transgenic plants were healthy. In 1998, after negotiations with four patent holders, the papaya growers switched en masse to the transgenic seeds and reclaimed their orchards. "Consumer acceptance has been great," reports Rusty Perry, who runs a papaya farm near Puna. "We've found that customers are more concerned with how the fruits look and taste than with whether they are transgenic...
...brought these drugs within reach of ordinary Africans. In fact, the people who make the drugs--American- and European-owned multinational pharmaceutical corporations--and their home governments, notably Washington, have worked hard to keep prices up by limiting exports to the Third World and vigorously enforcing patent rights. They argue that drug firms legitimately need the profits to finance research on new wonder drugs. They say it's not wise to offer cheap AIDS drugs without a proper medical infrastructure--that deadly, drug-resistant strains would emerge. But at what point does the human benefit to desperate, destitute countries outweigh...
...lawyer and top cop, the Attorney General oversees an enormous network of law-enforcement officers and attorneys, supervising the FBI, the INS, the DEA, the Witness Protection Program and the U.S. Marshals. As chief attorney, he prosecutes everything from tax fraud to money laundering to illegal gun sales to patent violations...
...decreased productivity. Other drugs in the pipeline target schizophrenia, anxiety phobias and various forms of senile dementia, most notably Alzheimer's. All told, drug companies are betting $6 billion a year on R. and D. in hopes of creating new blockbuster drugs like Eli Lilly's Prozac, whose patent expires...
Finally, we are unconvinced that Ashcroft would consistently serve the public interest. He has been dubbed "the senator from Claritin" by the St. Louis Post-Dispatch for his efforts to help the drug's producer, Schering-Plough, evade patent limitations and keep low-cost generic versions off of the market. Consumers would lose $11 billion from the extension and receive nothing in return; Ashcroft, on the other hand, received a $50,000 campaign donation...